Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Guenther

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Future Oncology (London, England)|March 13, 2026
The integrated 31-gene expression profile test identifies low-risk patients with cutaneous melanoma who can forego the SLNB procedure: results from a prospective, multicenter trialTimothy Beard, J Michael Guenther, Stanley P Leong, et al.
Acta Cardiologica|October 13, 2015
Target temperature management of 33 degrees C exerts beneficial haemodynamic effects after out-of-hospital cardiac arrestMathias Forkmann, Steffen Kolschmann, Luise Holzhauser, et al.
British Journal of Cancer|June 11, 2021
Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 studyMichael Guenther, Michael Haas, Volker Heinemann, et al.
British Journal of Cancer|August 25, 2020
Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 studyMichael Guenther, Michael Haas, Volker Heinemann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2023
Corrigendum to 'Nivolumab induces long-term remission in a patient with fusariosis' [Eur J Cancer 173 (2022) 91-94]Elham Khatamzas, Sibylle C Mellinghoff, Martin Thelen, et al.
Cancer Treatment Reviews|June 24, 2026
Targeting HER2 in urothelial carcinoma: from pathway inhibition to antibody-drug conjugatesHamed Wafa, Nils C H van Creij, Michael Guenther, et al.
JNCI Cancer Spectrum|May 19, 2022
Bacterial Lipopolysaccharide as a Negative Predictor of Adjuvant Gemcitabine Efficacy in Pancreatic CancerMichael Guenther, Lina Gil, Sai Agash Surendran, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|June 17, 2016
pH-Driven Self-Assembly of Acidic Microbial GlycolipidsNiki Baccile, Mohamed Selmane, Patrick Le Griel, et al.
Cancer Medicine|April 1, 2025
A Prospective, Multicenter Analysis of Recurrence-Free Survival After Sentinel Lymph Node Biopsy Decisions Influenced by the 31-GEPJ Michael Guenther, Andrew Ward, Brian J Martin, et al.
Surgery|December 3, 2023
Preoperative ultrasound elastography for postoperative pancreatic fistula prediction after pancreatoduodenectomy: A prospective studyViktor H von Ehrlich-Treuenstätt, Michael Guenther, Matthias Ilmer, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|March 13, 2026
The integrated 31-gene expression profile test identifies low-risk patients with cutaneous melanoma who can forego the SLNB procedure: results from a prospective, multicenter trialTimothy Beard, J Michael Guenther, Stanley P Leong, et al.
Acta Cardiologica|October 13, 2015
Target temperature management of 33 degrees C exerts beneficial haemodynamic effects after out-of-hospital cardiac arrestMathias Forkmann, Steffen Kolschmann, Luise Holzhauser, et al.
British Journal of Cancer|June 11, 2021
Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 studyMichael Guenther, Michael Haas, Volker Heinemann, et al.
British Journal of Cancer|August 25, 2020
Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 studyMichael Guenther, Michael Haas, Volker Heinemann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2023
Corrigendum to 'Nivolumab induces long-term remission in a patient with fusariosis' [Eur J Cancer 173 (2022) 91-94]Elham Khatamzas, Sibylle C Mellinghoff, Martin Thelen, et al.
Cancer Treatment Reviews|June 24, 2026
Targeting HER2 in urothelial carcinoma: from pathway inhibition to antibody-drug conjugatesHamed Wafa, Nils C H van Creij, Michael Guenther, et al.
JNCI Cancer Spectrum|May 19, 2022
Bacterial Lipopolysaccharide as a Negative Predictor of Adjuvant Gemcitabine Efficacy in Pancreatic CancerMichael Guenther, Lina Gil, Sai Agash Surendran, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|June 17, 2016
pH-Driven Self-Assembly of Acidic Microbial GlycolipidsNiki Baccile, Mohamed Selmane, Patrick Le Griel, et al.
Cancer Medicine|April 1, 2025
A Prospective, Multicenter Analysis of Recurrence-Free Survival After Sentinel Lymph Node Biopsy Decisions Influenced by the 31-GEPJ Michael Guenther, Andrew Ward, Brian J Martin, et al.
Surgery|December 3, 2023
Preoperative ultrasound elastography for postoperative pancreatic fistula prediction after pancreatoduodenectomy: A prospective studyViktor H von Ehrlich-Treuenstätt, Michael Guenther, Matthias Ilmer, et al.
Pageof 5